Growth IPOs are on a hot streak. This past week's IPOs continued the strong trading we've seen in the tech and health care sectors over the past 90 days. CarGurus and three medical device companies each had a strong debut, averaging a first-day pop of 45%.
...read more
OptiNose, which is commercializing a drug-device nasal spray for chronic rhinosinusitis, raised $120 million by offering 7.5 million shares at $16, within the range of $15 to $17. It had previously planned to offer 6.3 million shares. OptiNose plans to list on...read more
CarGurus leads the way with a $132 million offering in a week with four IPOs set to raise a combined $309 million. The online car marketplace is joined by two specialty medical device companies; a fourth company is commercializing a combination drug-device.
...read more
OptiNose, which is commercializing a drug-device nasal spray for chronic rhinosinusitis, announced terms for its IPO on Tuesday. The Yardley, PA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17....read more
US IPO Weekly Recap: CarGurus races up 72% in a week with 4 strong pops
Growth IPOs are on a hot streak. This past week's IPOs continued the strong trading we've seen in the tech and health care sectors over the past 90 days. CarGurus and three medical device companies each had a strong debut, averaging a first-day pop of 45%. ...read more
OptiNose prices upsized IPO at $16 midpoint
OptiNose, which is commercializing a drug-device nasal spray for chronic rhinosinusitis, raised $120 million by offering 7.5 million shares at $16, within the range of $15 to $17. It had previously planned to offer 6.3 million shares. OptiNose plans to list on...read more
US IPO Week Ahead: CarGurus to headline 4-IPO week
CarGurus leads the way with a $132 million offering in a week with four IPOs set to raise a combined $309 million. The online car marketplace is joined by two specialty medical device companies; a fourth company is commercializing a combination drug-device. ...read more
Medical device company OptiNose sets terms for $100 million IPO
OptiNose, which is commercializing a drug-device nasal spray for chronic rhinosinusitis, announced terms for its IPO on Tuesday. The Yardley, PA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17....read more